Clindamycin Phosphate

ANDA 62913, held by Marsam Pharms LLC. Clindamycin Phosphate.

As of Nov 15, 2026, ANDA 62913 (Clindamycin Phosphate), held by Marsam Pharms LLC, was first approved by FDA on Oct 20, 1988, with 1 approved supplement and 0 published complete response letters.

First approved: Oct 20, 1988
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Oct 20, 1988	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Clindamycin PhosphateEQ 150MG BASE/ML · injectable;injection	Clindamycin Phosphate	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Jan 27, 1994	Supplement 8Labeling	Approved	None posted
Oct 20, 1988	Original application	Approved	None posted

Identifiers

Application: ANDA 62913
Drugs@FDA: Overview at FDA
Company: Marsam Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters